This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for the ventana medical systems, inc. 's (ventana) pathway anti-her-2/neu (4b5) rabbit monoclonal primary antibody (pathway her2 (4b5)) is a rabbit monoclonal antibody intended for laboratory use for the semi-quantitative detection of her2 antigen in sections of formalin-fixed, paraffin-embedded normal and neoplastic tissue following staining on a benchmark xt or benchmark ultra instrument. It is indicated as an aid in the assessment of breast cancer patients for whom herceptin® (trastuzumab) or kadcyla® (ado-trastuzumab emtansine) treatment is being considered. Note: all of the patients in the herceptin clinical trials were selected using a clinical trial assay. None of the patients in those trials were selected using pathway anti-her-2/neu (4b5). Pathway anti-her-2/neu (4b5) was compared to pathway her-2 (clone cb11) primary antibody on an independent sample set and found to provide acceptably concordant results. The actual correlation of pathway anti-her-2/neu (4b5) to clinical outcome has not been established. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (ivd) use.
| Device | PATHWAY Anti-HER-2/neu (4B5) Rabbit Monoclonal Primary Antibody |
| Classification Name | System, Test, Her-2/neu, Ihc |
| Generic Name | System, Test, Her-2/neu, Ihc |
| Applicant | VENTANA MEDICAL SYSTEMS, INC. |
| Date Received | 2019-02-13 |
| Decision Date | 2019-05-03 |
| PMA | P990081 |
| Supplement | S039 |
| Product Code | MVC |
| Advisory Committee | Pathology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | VENTANA MEDICAL SYSTEMS, INC. 1910 E. Innovation Park Dr. tucson, AZ 85755 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P990081 | Original Filing | |
| S050 | 2022-10-14 | 30-day Notice |
| S049 | ||
| S048 | 2022-07-12 | 30-day Notice |
| S047 | ||
| S046 | 2022-02-16 | Special (immediate Track) |
| S045 | 2022-01-28 | 135 Review Track For 30-day Notice |
| S044 | 2021-02-22 | Real-time Process |
| S043 | 2020-08-26 | Real-time Process |
| S042 | 2020-01-13 | Real-time Process |
| S041 | 2019-08-22 | Real-time Process |
| S040 | 2019-04-09 | 30-day Notice |
| S039 | 2019-02-13 | Normal 180 Day Track |
| S038 | 2018-06-18 | Real-time Process |
| S037 | ||
| S036 | ||
| S035 | 2016-11-15 | Normal 180 Day Track |
| S034 | 2015-12-10 | 135 Review Track For 30-day Notice |
| S033 | 2015-08-26 | 30-day Notice |
| S032 | 2015-08-14 | 30-day Notice |
| S031 | 2014-10-27 | 30-day Notice |
| S030 | 2014-06-16 | 135 Review Track For 30-day Notice |
| S029 | 2014-02-14 | Normal 180 Day Track |
| S028 | 2014-02-06 | Real-time Process |
| S027 | 2014-01-22 | Real-time Process |
| S026 | 2014-01-06 | 30-day Notice |
| S025 | 2013-12-27 | 30-day Notice |
| S024 | 2013-11-12 | 30-day Notice |
| S023 | 2013-10-28 | 30-day Notice |
| S022 | 2013-08-30 | 30-day Notice |
| S021 | 2013-07-30 | 30-day Notice |
| S020 | 2013-05-07 | 135 Review Track For 30-day Notice |
| S019 | 2013-05-06 | Real-time Process |
| S018 | 2013-04-17 | 30-day Notice |
| S017 | 2013-03-12 | Real-time Process |
| S016 | 2013-03-04 | 30-day Notice |
| S015 | 2013-01-14 | Real-time Process |
| S014 | 2012-08-31 | Real-time Process |
| S013 | 2012-07-27 | 30-day Notice |
| S012 | 2012-07-25 | Real-time Process |
| S011 | 2011-05-23 | Normal 180 Day Track |
| S010 | 2011-01-03 | Normal 180 Day Track |
| S009 | ||
| S008 | 2010-10-21 | Special (immediate Track) |
| S007 | 2007-11-19 | 30-day Notice |
| S006 | 2007-06-27 | 30-day Notice |
| S005 | 2007-03-02 | Special (immediate Track) |
| S004 | 2006-08-28 | 30-day Notice |
| S003 | 2006-05-04 | Normal 180 Day Track |
| S002 | 2005-09-06 | Real-time Process |
| S001 | 2002-08-20 | Normal 180 Day Track |